Advertisement

Pediatric Drugs

, Volume 10, Issue 1, pp 1–7 | Cite as

Dysmenorrhea in Adolescents

Diagnosis and Treatment
  • Linda FrenchEmail author
Therapy In Practice

Abstract

Dysmenorrhea occurs in the majority of adolescent girls and is the leading cause of recurrent short-term school absence in this group. In the vast majority of cases, a presumptive diagnosis of primary dysmenorrhea can be made based on a typical history of low anterior pelvic pain coinciding with the onset of menses and lasting 1–3 days with a negative physical examination. Risk factors for primary dysmenorrhea include nulliparity, heavy menstrual flow, and smoking. Poor mental health and social supports are other associations. Empiric therapy for primary dysmenorrhea can be initiated without diagnostic testing. Effective therapies include NSAIDs, oral contraceptives, and pharmacologic suppression of menstrual cycles. In atypical, severe, or refractory cases, imaging and/or laparoscopy should be performed to investigate secondary causes of dysmenorrhea. The most common cause of secondary dysmenorrhea is endometriosis, the treatment of which may include medical and surgical approaches. Pharmacologic treatment of young women with pain related to endometriosis is similar to treatment of primary dysmenorrhea but may infrequently include gonadotropin-releasing hormone agonists in severe refractory cases.

Keywords

Endometriosis Anastrozole Goserelin Transcutaneous Electrical Nerve Stimulation Sham Acupuncture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

No sources of funding were used to assist in the preparation of this article. The authors have no conflicts of interest that are directly relevant to the content of this article.

References

  1. 1.
    Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol 2001 Feb; 14(1): 3–8PubMedCrossRefGoogle Scholar
  2. 2.
    Banikarim C, Chacko MR, Kelder SH. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med 2000 Dec; 154(12): 1226–9PubMedGoogle Scholar
  3. 3.
    Strinic T, Bukovic D, Pavelic L, et al. Anthropological and clinical characteristics in adolescent women with dysmenorrhea. Coll Antropol 2003 Dec; 27(2): 707–11PubMedGoogle Scholar
  4. 4.
    Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics 1981 Nov; 68(5): 661–4PubMedGoogle Scholar
  5. 5.
    Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 1990 Jul; 97(7): 588–94PubMedCrossRefGoogle Scholar
  6. 6.
    Jabbour HN, Sales KJ, Smith OP, et al. Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Mol Cell Endocrinol 2006 Jun 27; 252(1-2): 191–200PubMedCrossRefGoogle Scholar
  7. 7.
    Liedman R, Skillern L, James I, et al. Validation of a test model of induced dysmenorrhea. Acta Obstet Gynecol Scand 2006; 85: 451–7PubMedCrossRefGoogle Scholar
  8. 8.
    Burnett MA, Antao V, Black A, et al. Prevalence of primary dysmenorrhea in Canada. J Obstet Gynaecol Can 2005 Aug; 27(8): 765–70PubMedGoogle Scholar
  9. 9.
    Teperi J, Rimpela M. Menstrual pain, health, and behaviour in girls. Soc Sci Med 1989; 29(2): 163–9PubMedCrossRefGoogle Scholar
  10. 10.
    Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 1982 Nov 15; 144(6): 655–60PubMedGoogle Scholar
  11. 11.
    Juang CM, Yen MS, Twu NF, et al. Impact of pregnancy on primary dysmenorrhea. Int J Gynaecol Obstet 2006 Mar; 92(3): 221–7PubMedCrossRefGoogle Scholar
  12. 12.
    Harlow SD, Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol 1996 Nov; 103(11): 1134–42PubMedCrossRefGoogle Scholar
  13. 13.
    Parazzini F, Tozzi L, Mezzopane R, et al. Cigarette smoking, alcohol consumption, and risk of primary dysmenorrhea. Epidemiology 1994 Jul; 5(4): 469–72PubMedCrossRefGoogle Scholar
  14. 14.
    Rapkin AJ, Tsao JC, Turk N, et al. Relationships among self-rated tanner staging, hormones, and psychosocial factors in healthy female adolescents. J Pediatr Adolesc Gynecol 2006 Jun; 19(3): 181–7PubMedCrossRefGoogle Scholar
  15. 15.
    Montero P, Bernis C, Fernandez V, et al. Influence of body mass index and slimming habits on menstrual pain and cycle irregularity. J Biosoc Sci 1996 Jul; 28(3): 315–23PubMedCrossRefGoogle Scholar
  16. 16.
    American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67(5): 817–21CrossRefGoogle Scholar
  17. 17.
    Proctor M, Farquhar C. The diagnosis and management of dysmenorrhoea. BMJ 2006; 132: 1134–8CrossRefGoogle Scholar
  18. 18.
    Farquhar C. Endometriosis. BMJ 2007; 334: 249–53PubMedCrossRefGoogle Scholar
  19. 19.
    US Preventive Services Task Force, Agency for Healthcare Research and Quality. Screening for gonorrhea: summary of recommendations [online]. Available from URL: http://www.ahrq.gov/clinic/uspstf/uspsgono.htm [Accessed 2007 Nov 21]
  20. 20.
    Moore J, Copley S, Morris J, et al. A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis. Ultrasound Obstet Gynecol 2002 Dec; 20(6): 630–4PubMedCrossRefGoogle Scholar
  21. 21.
    Exacoustos C, Zupi E, Carusotti C, et al. Staging of pelvic endometriosis: role of sonographic appearance in determining extension of disease and modulating surgical approach. J Am Assoc Gynecol Laparosc 2003 Aug; 10(3): 378–82PubMedCrossRefGoogle Scholar
  22. 22.
    Dessole S, Farina M, Rubattu G, et al. Sonovaginography is a new technique for assessing rectovaginal endometriosis. Fertil Steril 2003 Apr; 79(4): 1023–7PubMedCrossRefGoogle Scholar
  23. 23.
    Stratton P, Winkel C, Premkumar A, et al. Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis. Fertil Steril 2003 May; 79(5): 1078–85PubMedCrossRefGoogle Scholar
  24. 24.
    Practice Committee of the American Society of Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril 2006 Nov; 86(5 Suppl.): S18–27Google Scholar
  25. 25.
    Ballweg ML. Impact of endometriosis on women’s health: comparative historical data show that the earlier the onset, the more severe the disease. Best Pract Res Clin Obstet Gynaecol 2004 Apr; 18(2): 201–18PubMedCrossRefGoogle Scholar
  26. 26.
    Proctor ML, Farquhar CM. Dysmenorrhoea. In: Group BP, editor. Clinical evidence. London: BMJ Publishing Group, 2003: 2058–78Google Scholar
  27. 27.
    Maia Jr H, Maltez A, Studard E, et al. Effect of the menstrual cycle and oral contraceptives on cyclooxygenase-2 expression in the endometrium. Gynecol Endocrinol 2005 Jul; 21(1): 57–61PubMedCrossRefGoogle Scholar
  28. 28.
    Davis AR, Westhoff C, O’Connell K, et al. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. Obstet Gynecol 2005 Jul; 106(1): 97–104PubMedCrossRefGoogle Scholar
  29. 29.
    Hendrix SL, Alexander NJ. Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive. Contraception 2002 Dec; 66(6): 393–9PubMedCrossRefGoogle Scholar
  30. 30.
    Milsom I, Sundell G, Andersch B. The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea. Contraception 1990 Nov; 42(5): 497–506PubMedCrossRefGoogle Scholar
  31. 31.
    Edelman AB, Gallo MF, Jensen JT, et al. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev 2005; (3): CD004695Google Scholar
  32. 32.
    Sulak PJ, Kuehl TJ, Ortiz M, et al. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 2002 Jun; 186(6): 1142–9PubMedCrossRefGoogle Scholar
  33. 33.
    Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception 2003 Feb; 67(2): 87–91PubMedCrossRefGoogle Scholar
  34. 34.
    Harel Z, Riggs S, Vaz R, et al. Adolescents’ experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynecol 2005 Apr; 18(2): 85–90PubMedCrossRefGoogle Scholar
  35. 35.
    Ziaei S, Rajaei L, Faghihzadeh S, et al. Comparative study and evaluation of side effects of low-dose contraceptive pills administered by the oral and vaginal route. Contraception 2002 May; 65(5): 329–31PubMedCrossRefGoogle Scholar
  36. 36.
    Audet MC, Moreau M, Koltun WD, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA 2001 May 9; 285(18): 2347–54PubMedCrossRefGoogle Scholar
  37. 37.
    Facchinetti F, Sgarbi L, Piccinini F, et al. A comparison of glyceryl trinitrate with diclofenac for the treatment of primary dysmenorrhea: an open, randomized, cross-over trial. Gynecol Endocrinol 2002 Feb; 16(1): 39–43PubMedGoogle Scholar
  38. 38.
    Akerlund M, Andersson KE. Effects of terbutaline on human myometrial activity and endometrial blood flow. Obstet Gynecol 1976 May; 47(5): 529–35PubMedGoogle Scholar
  39. 39.
    Andersson KE, Ulmsten U. Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhoea. Br J Obstet Gynaecol 1978 Feb; 85(2): 142–8PubMedCrossRefGoogle Scholar
  40. 40.
    Selak V, Farquhar C, Prentice A, et al. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2001; (4): CD000068Google Scholar
  41. 41.
    Meresman GF, Bilotas M, Abello V, et al. Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis. Fertil Steril 2005 Aug; 84(2): 459–63PubMedCrossRefGoogle Scholar
  42. 42.
    Hefler LA, Grimm C, van Trotsenburg M, et al. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study. Fertil Steril 2005 Oct; 84(4): 1033–6PubMedCrossRefGoogle Scholar
  43. 43.
    Amsterdam LL, Gentry W, Jobanputra S, et al. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005 Aug; 84(2): 300–4PubMedCrossRefGoogle Scholar
  44. 44.
    Ailawadi RK, Jobanputra S, Kataria M, et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril 2004 Feb; 81(2): 290–6PubMedCrossRefGoogle Scholar
  45. 45.
    Soysal S, Soysal ME, Ozer S, et al. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod 2004 Jan; 19(1): 160–7PubMedCrossRefGoogle Scholar
  46. 46.
    Olive DL, Lindheim SR, Pritts EA. New medical treatments for endometriosis. Best Pract Res Clin Obstet Gynaecol 2004 Apr; 18(2): 319–28PubMedCrossRefGoogle Scholar
  47. 47.
    Ferrero S, Abbamonte LH, Anserini P, et al. Future perspectives in the medical treatment of endometriosis. Obstet Gynecol Surv 2005 Dec; 60(12): 817–26PubMedCrossRefGoogle Scholar
  48. 48.
    Barnard ND, Scialli AR, Hurlock D, et al. Diet and sex-hormone binding globulin, dysmenorrhea, and premenstrual symptoms. Obstet Gynecol 2000 Feb; 95(2): 245–50PubMedCrossRefGoogle Scholar
  49. 49.
    Nagata C, Hirokawa K, Shimizu N, et al. Associations of menstrual pain with intakes of soy, fat and dietary fiber in Japanese women. Eur J Clin Nutr 2005 Jan; 59(1): 88–92PubMedCrossRefGoogle Scholar
  50. 50.
    Gokhale LB. Curative treatment of primary (spasmodic) dysmenorrhoea. Indian J Med Res 1996 Apr; 103: 227–31PubMedGoogle Scholar
  51. 51.
    Vitamin E for dysmenorrhea. Bandolier, 2005 [online]. Available from URL: http://www.jr2.ox.ac.uk/bandolier/bandl36/bl36-6.html [Accessed 2007 Nov 14]
  52. 52.
    Ziaei S, Zakeri M, Kazemnejad A. A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea. BJOG 2005 Apr; 112(4): 466–9PubMedCrossRefGoogle Scholar
  53. 53.
    Vivekananthan DP, Penn MS, Sapp SK, et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003 Jun 14; 361(9374): 2017–23PubMedCrossRefGoogle Scholar
  54. 54.
    Harel Z, Biro FM, Kottenhahn RK, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol 1996 Apr; 174(4): 1335–8PubMedCrossRefGoogle Scholar
  55. 55.
    Deutch B. Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. Eur J Clin Nutr 1995 Jul; 49(7): 508–16PubMedGoogle Scholar
  56. 56.
    Eccles NK. A randomized, double-blinded, placebo-controlled pilot study to investigate the effectiveness of a static magnet to relieve dysmenorrhea. J Altern Complement Med 2005 Aug; 11(4): 681–7PubMedCrossRefGoogle Scholar
  57. 57.
    Helms JM. Acupuncture for the management of primary dysmenorrhea. Obstet Gynecol 1987 Jan; 69(1): 51–6PubMedGoogle Scholar
  58. 58.
    Pouresmail Z, Ibrahimzadeh R. Effects of acupressure and ibuprofen on the severity of primary dysmenorrhea. J Tradit Chin Med 2002 Sep; 22(3): 205–10PubMedGoogle Scholar
  59. 59.
    Taylor D, Miaskowski C, Kohn J. A randomized clinical trial of the effectiveness of an acupressure device (relief brief) for managing symptoms of dysmenorrhea. J Altern Complement Med 2002 Jun; 8(3): 357–70PubMedCrossRefGoogle Scholar
  60. 60.
    Dawood MY, Ramos J. Transcutaneous electrical nerve stimulation (TENS) for the treatment of primary dysmenorrhea: a randomized crossover comparison with placebo TENS and ibuprofen. Obstet Gynecol 1990 Apr; 75(4): 656–60PubMedGoogle Scholar
  61. 61.
    Proctor ML, Smith CA, Farquhar CM, et al. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea. Cochrane Database Syst Rev 2002; (1): CD002123Google Scholar
  62. 62.
    Akin MD, Weingand KW, Hengehold DA, et al. Continuous low-level topical heat in the treatment of dysmenorrhea. Obstet Gynecol 2001 Mar; 97(3): 343–9PubMedCrossRefGoogle Scholar
  63. 63.
    Hondras MA, Long CR, Brennan PC. Spinal manipulative therapy versus a low force mimic maneuver for women with primary dysmenorrhea: a randomized, observer-blinded, clinical trial. Pain 1999 May; 81(1-2): 105–14PubMedCrossRefGoogle Scholar
  64. 64.
    Proctor ML, Hing W, Johnson TC, et al. Spinal manipulation for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2001; (4): CD002119Google Scholar
  65. 65.
    Wilson ML, Farquhar CM, Sinclair OJ, et al. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2000; (2): CD001896Google Scholar

Copyright information

© Adis Data Information BV 2008

Authors and Affiliations

  1. 1.Department of Family MedicineUniversity of Toledo, College of MedicineToledoUSA

Personalised recommendations